PCL Lab LLC

PCL Lab LLC was paid $1.17M by Medicaid between Jan 2018 and Nov 2023, across 21 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 77% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Colorado

Rank by total paid#23 of 91

Median peer was paid$53K

This provider vs. median22×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	492	$4K
2019	1,106	$10K
2020	3,095	$224K
2021	12,342	$528K
2022	10,428	$385K
2023	2,610	$22K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	77%	12,765	7,976	$902K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	18%	9,939	6,612	$216K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	1.2%	1,280	244	$14K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	1,982	1,330	$10K
80053	Comprehensive metabolic panel	<1%	1,409	968	$10K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	534	469	$6K
84443	Thyroid stimulating hormone (TSH)	<1%	494	396	$3K
80048	Basic metabolic panel (calcium, ionized)	<1%	374	273	$3K
83036	Hemoglobin; glycosylated (A1C)	<1%	327	282	$2K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	137	98	$2K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	36	33	$2K
80061	Lipid panel	<1%	112	84	$943.94

9 more codes

81001		<1%	257	$630.93
80050	General health panel	<1%	14	$469.95
81003		<1%	280	$459.00
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	34	$334.22
82607		<1%	21	$180.96
82746		<1%	25	$161.70
83735		<1%	25	$107.20
A0080	Non-emergency transportation, per mile - vehicle provided by volunteer (individual or organization), with no vested interest	0%	13	$0.00
36415	Collection of venous blood by venipuncture	0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialMENGESHA, JOYCE (OWNER)